Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
0 Views
administrator
07/16/23
Visit http://www.ecancer.org for more.
In a press conference at SABCS 2014, Prof Rakovitch (Sunnybrook Research Institute, Toronto, Canada) discusses the use of a multigene test called Oncotype DX DCIS Score (DCIS Score) as a predictor of risk of disease recurrence for patients with ductal carcinoma in situ (DCIS).
DCIS Score may be a good predictor of whether a patient with DCIS who was treated with breast-conserving surgery alone would experience recurrence of DCIS or invasive breast cancer in the same breast.
-
Category
Show more
Facebook Comments
No comments found